Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.
Revenue (Most Recent Fiscal Year) | $0.01M |
Net Income (Most Recent Fiscal Year) | $-5.29M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | -- |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.64 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -58744.45% |
Net Margin (Trailing 12 Months) | -- |
Return on Equity (Trailing 12 Months) | -41.48% |
Return on Assets (Trailing 12 Months) | -40.22% |
Current Ratio (Most Recent Fiscal Quarter) | 27.68 |
Quick Ratio (Most Recent Fiscal Quarter) | 27.67 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 0.41 |
Book Value per Share (Most Recent Fiscal Quarter) | $7.48 |
Earnings per Share (Most Recent Fiscal Quarter) | $-1.21 |
Earnings per Share (Most Recent Fiscal Year) | $-3.76 |
Diluted Earnings per Share (Trailing 12 Months) | $-3.71 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Biotechnology |
Common Shares Outstanding | 1.36M |
Free Float | 1.31M |
Market Capitalization | $6.53M |
Average Volume (Last 20 Days) | 0.01M |
Beta (Past 60 Months) | 2.21 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 3.30% |
Percentage Held By Institutions (Latest 13F Reports) | 1.42% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |